Serious Warnings & Contraindications (FDA Labeling):** * **Tirzepatide, Semaglutide, Liraglutide:** Carry an **FDA Boxed Warning** for risk of thyroid C-cell tumors (based on rodent studies)
Cons: No approved human use outside prescription medications
Wegovy ~16.9% average body weight loss Boosts metabolic & cardiovascular health Proven, long-established safety profile Weekly injection, easy to use Key Insights: Wegovy vs Ozempic Wegovy and Ozempic are both semaglutide-based injections, but their prescribing pathways differ based on their intended medical uses and treatment goals
The problem is that diet and exercise dont usually produce weight loss to fix the cholesterol problem in patients with severe obesity
The STEP 3 trial combined Wegovy with intensive behavioural support, including structured exercise guidance, and produced 16% average weight loss, reflecting how much lifestyle structure compounds the drug's effect
Retatrutide Research Grade 99% Purity Third-Party Verified Reference Strength: 40mg CAS: 2381089-83-2 Formula: C222H342N50O65 Molecular Weight: 4755.51 Chemical Name / Amino Acid Sequence: his-aib-glu-gly-thr-phe-thr-ser-asp-tyr-ser-ile-ala-leu-glu-gln-ala-arg-glu-phe-ile-ala-trp-leu-val-kgr-gly-arg (GIP/GLP-1/glucagon triple agonist) Retatrutide R899,00 R1999,00Price range: R899,00 through R1999,00 Triple receptor agonist studied for metabolic regulation and body weight management in research Included with your purchase Each qualifying product includes 3ml of 0.9% Benzyl Alcohol Bacteriostatic Water